References
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68 (6):394–424. doi:https://doi.org/10.3322/caac.21492
- Hawk ET, Umar A, Richmond E, Viner JL. Prevention and therapy of colorectal cancer. Med Clin North Am. 2005; 89 (1):85–110. doi:https://doi.org/10.1016/j.mcna.2004.08.003
- Wilson BJ, Schatton T, Frank MH, Frank NY. Colorectal cancer stem cells: biology and therapeutic implications. Curr Colorectal Cancer Rep. 2011; 7 (2):128–35. doi:https://doi.org/10.1007/s.11888-011-0093-2
- O'Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature. 2007; 445 (7123):106–10. doi:https://doi.org/10.1038/nature05372
- Zhou Y, Xia L, Wang H, Oyang L, Su M, Liu Q, Lin J, Tan S, Tian Y, Liao Q, et al. Cancer stem cells in progression of colorectal cancer. Oncotarget. 2018; 9 (70):33403–15. https://doi.org/https://doi.org/10.18632/oncotarget.23607 doi:https://doi.org/10.18632/oncotarget.23607
- Therkildsen C, Bergmann TK, Henrichsen-Schnack T, Ladelund S, Nilbert M. The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: a systematic review and meta-analysis. Acta Oncol. 2014; 53 (7):852–64. doi:https://doi.org/10.3109/0284186X.2014.895036
- Janssen K-P, Alberici P, Fsihi H, Gaspar C, Breukel C, Franken P, Rosty C, Abal M, El Marjou F, Smits R, et al. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression. Gastroenterology. 2006; 131 (4):1096–109. doi:https://doi.org/10.1053/j.gastro.2006.08.011
- Moon BS, Jeong WJ, Park J, Kim TI, Min DS, Choi KY. Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling. J. Natl Cancer Inst. 2014; 106 (2):djt373. doi:https://doi.org/10.1093/jnci/djt373
- Wang Q, Shi Y-L, Zhou K, Wang L-L, Yan Z-X, Liu Y-L, Xu L-L, Zhao S-W, Chu H-L, Shi T-T, et al. PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer. Cell Death Dis. 2018; 9 (7):739. doi:https://doi.org/10.1038/s41419-018-0776-6
- De Roock W, Claes B, Bernasconi D, De Schutter J, Biesmans B, Fountzilas G, Kalogeras KT, Kotoula V, Papamichael D, Laurent-Puig P, et al. Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis. Lancet Oncol. 2010; 11 (8):753–62. doi:https://doi.org/10.1016/S1470-2045(10)70130-3
- Céspedes MV, Unzueta U, Aviñó A, Gallardo A, Álamo P, Sala R, Sánchez‐Chardi A, Casanova I, Mangues MA, Lopez‐Pousa A, et al. Selective depletion of metastatic stem cells as therapy for human colorectal cancer. EMBO Mol Med. 2018; 10 (10)pii: e8772. doi:https://doi.org/10.15252/emmm.201708772
- Wu W, Cao J, Ji Z, Wang J, Jiang T, Ding H. Co-expression of Lgr5 and CXCR4 characterizes cancer stem-like cells of colorectal cancer. Oncotarget. 2016; 7 (49):81144–55. doi:https://doi.org/10.18632/oncotarget.13214
- Scala S . Molecular pathways: targeting the CXCR4-CXCL12 axis-untapped potential in the tumor microenvironment. Clin Cancer Res. 2015; 21 (19):4278–85. doi:https://doi.org/10.1158/1078-0432.CCR-14-0914
- Voutsadakis IA. Pluripotency transcription factors in the pathogenesis of colorectal cancer and implications for prognosis. Biomark Med. 2015; 9 (4):349–61. https://doi.org/https://doi.org/10.2217/bmm.15.4 doi:https://doi.org/10.2217/bmm.15.4
- O'Brien CA, Kreso A, Jamieson CH. Cancer stem cells and self-renewal. Clin Cancer Res. 2010; 16 (12):3113–20. doi:https://doi.org/10.1158/1078-0432.CCR-09-2824
- Hadjimichael C, Chanoumidou K, Papadopoulou N, Arampatzi P, Papamatheakis J, Kretsovali A. Common stemness regulators of embryonic and cancer stem cells. World J Stem Cells. 2015; 7 (9):1150–84. doi:https://doi.org/10.4252/wjsc.v7.i9.1150.
- Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006; 126 (4):663–76. doi:https://doi.org/10.1016/j.cell.2006.07.024
- Li D-w, Tang H-m, Fan J-w, Yan D-w, Zhou C-z, Li S-x, Wang X-l, Peng Z-h. Expression level of Bmi-1 oncoprotein is associated with progression and prognosis in colon cancer. J Cancer Res Clin Oncol. 2010; 136 (7):997–1006. doi:https://doi.org/10.1007/s00432-009-0745-7
- Du J, Li Y, Li J, Zheng J. Polycomb group protein Bmi1 expression in colon cancers predicts the survival. Med Oncol. 2010; 27 (4):1273–6. doi:https://doi.org/10.1007/s12032-009-9373-y
- Han X, Fang X, Lou X, Hua D, Ding W, Foltz G, Hood L, Yuan Y, Lin B. Silencing SOX2 induced mesenchymal-epithelial transition and its expression predicts liver and lymph node metastasis of CRC patients. PLoS One. 2012; 7 (8):e41335. doi:https://doi.org/10.1371/journal.pone.0041335
- Miyoshi N, Fujino S, Ohue M, Yasui M, Takahashi Y, Sugimura K, Tomokuni A, Akita H, Kobayashi S, Takahashi H, et al. The POU5F1 gene expression in colorectal cancer: a novel prognostic marker. Surg Today. 2018; 48 (7):709–15. https://doi.org/https://doi.org/10.1007/s00595-018-1644-9 doi:https://doi.org/10.1007/s00595-018-1644-9
- Zhou H, Hu YU, Wang W, Mao Y, Zhu J, Zhou B, Sun J, Zhang X. Expression of Oct-4 is significantly associated with the development and prognosis of colorectal cancer. Oncol Lett. 2015; 10 (2):691–6. doi:https://doi.org/10.3892/ol.2015.3269
- Yun J, Mullarky E, Lu C, Bosch KN, Kavalier A, Rivera K, Roper J, Chio IIC, Giannopoulou EG, Rago C, et al. Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH. Science. 2015; 350 (6266):1391–6. doi:https://doi.org/10.1126/science.aaa5004
- Peixoto J, Lima J. Metabolic traits of cancer stem cells. Dis Model Mech. 2018;11(8):dmm033464. pii: . doi:https://doi.org/10.1242/dmm.033464
- Ancey PB, Contat C, Meylan E. Glucose transporters in cancer - from tumor cells to the tumor microenvironment. Febs J. 2018; 285 (16):2926–43. https://doi.org/https://doi.org/10.1111/febs.14577. doi:https://doi.org/10.1111/febs.14577
- Ngo B, Van Riper JM, Cantley LC, Yun J. Targeting cancer vulnerabilities with high-dose vitamin C. Nat Rev Cancer. 2019; 19 (5):271–82. doi:https://doi.org/10.1038/s41568-019-0135-7
- Mayland CR, Bennett MI, Allan K. Vitamin C deficiency in cancer patients. Palliat Med. 2005; 19 (1):17–20. doi:https://doi.org/10.1191/0269216305pm970oa
- Saygili E, Konukoglu D, Papila C, Akcay T. Levels of plasma vitamin e, vitamin C, TBARS, and cholesterol in male patients with colorectal tumors. Biochemistry. 2003; 68 (3):325–8. doi:https://doi.org/10.1023/a:1023010418230
- Moyad MA, Combs MA, Vrablic AS, Velasquez J, Turner B, Bernal S. Vitamin C metabolites, independent of smoking status, significantly enhance leukocyte, but not plasma ascorbate concentrations. Adv Therapy. 2008; 25 (10):995–1009. doi:https://doi.org/10.1007/s12325-008-0106-y
- Cimmino L, Neel BG, Aifantis I. Vitamin C in stem cell reprogramming and cancer. Trends Cell Biol. 2018; 28 (9):698–708. doi:https://doi.org/10.1016/j.tcb.2018.04.001
- Kreso A, van Galen P, Pedley NM, Lima-Fernandes E, Frelin C, Davis T, Cao L, Baiazitov R, Du W, Sydorenko N, et al. Self-renewal as a therapeutic target in human colorectal cancer. Nat Med. 2014; 20 (1):29–36. doi:https://doi.org/10.1038/nm.3418
- Sam MR, Ahangar P, Nejati V, Habibian R. Treatment of LS174T colorectal cancer stem-like cells with n-3 PUFAs induces growth suppression through inhibition of survivin expression and induction of caspase-3 activation. Cell Oncol (Dordr)). 2016; 39 (1):69–77. doi:https://doi.org/10.1007/s13402-015-0254-4
- de Padua MC, Delodi G, Vučetić M, Durivault J, Vial V, Bayer P, Noleto GR, Mazure NM, Ždralević M, Pouysségur J, et al. Disrupting glucose-6-phosphate isomerase fully suppresses the "Warburg effect" and activates OXPHOS with minimal impact on tumor growth except in hypoxia. Oncotarget. 2017; 8 (50):87623–37. doi:https://doi.org/10.18632/oncotarget.21007
- Ahmed D, Eide PW, Eilertsen IA, Danielsen SA, Eknaes M, Hektoen M, Lind GE, Lothe RA. Epigenetic and genetic features of 24 colon cancer cell lines. Oncogenesis. 2013; 2:e71. doi:https://doi.org/10.1038/oncsis.2013.35
- Giannini G, Ristori E, Cerignoli F, Rinaldi C, Zani M, Viel A, Ottini L, Crescenzi M, Martinotti S, Bignami M, et al. Human MRE11 is inactivated in mismatch repair-deficient cancers. EMBO Rep. 2002; 3 (3):248–54. https://doi.org/https://doi.org/10.1093/embo-reports/kvf044 doi:https://doi.org/10.1093/embo-reports/kvf044
- Bracht K, Nicholls AM, Liu Y, Bodmer WF. 5-Fluorouracil response in a large panel of colorectal cancer cell lines is associated with mismatch repair deficiency. Br J Cancer. 2010; 103 (3):340–6. doi:https://doi.org/10.1038/sj.bjc.6605780
- Efstathiou JA, Liu D, Wheeler JM, Kim HC, Beck NE, Ilyas M, Karayiannakis AJ, Mortensen NJ, Kmiot W, Playford RJ, et al. Mutated epithelial cadherin is associated with increased tumorigenicity and loss of adhesion and of responsiveness to the motogenic trefoil factor 2 in colon carcinoma cells. Proc Natl Acad Sci U S A. 1999; 96 (5):2316–21. doi:https://doi.org/10.1073/pnas.96.5.2316
- Lim JY, Kim D, Kim BR, Jun JS, Yeom JS, Park JS, Seo J-H, Park CH, Woo HO, Youn H-S, et al. Vitamin C induces apoptosis in AGS cells via production of ROS of mitochondria. Oncol Lett. 2016; 12 (5):4270–6. doi:https://doi.org/10.3892/ol.2016.5212
- Mustafi S, Sant DW, Liu ZJ, Wang G. Ascorbate induces apoptosis in melanoma cells by suppressing Clusterin expression. Sci Rep. 2017; 7 (1):3671. doi:https://doi.org/10.1038/s41598-017-03893-5
- Deubzer B, Mayer F, Kuçi Z, Niewisch M, Merkel G, Handgretinger R, Bruchelt G. H(2)O(2)-mediated cytotoxicity of pharmacologic ascorbate concentrations to neuroblastoma cells: potential role of lactate and ferritin . Cell Physiol Biochem. 2010; 25 (6):767–74. https://doi.org/https://doi.org/10.1159/000315098 doi:https://doi.org/10.1159/000315098
- Park S, Han S-S, Park CH, Hahm E-R, Lee SJ, Park HK, Lee S-H, Kim WS, Jung CW, Park K, et al. L-Ascorbic acid induces apoptosis in acute myeloid leukemia cells via hydrogen peroxide-mediated mechanisms. Int J Biochem Cell Biol. 2004; 36 (11):2180–95. doi:https://doi.org/10.1016/j.biocel. 2004.04.005
- Kim JE, Kang JS, Lee WJ. Vitamin C induces apoptosis in human colon cancer cell line, HCT-8 via the modulation of calcium influx in endoplasmic reticulum and the dissociation of bad from 14-3-3β. Immune Netw. 2012; 12 (5):189–95. https://doi.org/https://doi.org/10.4110/in.2012.12.5.189 doi:https://doi.org/10.4110/in.2012.12.5.189
- Jiang C, Ma S, Hu R, Wang X, Li M, Tian F, Jiang W, Zhu L, Bian Z. Effect of CXCR4 on apoptosis in osteosarcoma cells via the PI3K/Akt/NF-κβ signaling pathway. J Cell Physiol Biochem. 2018; 46 (6):2250–60. doi:https://doi.org/10.1159/000489593
- Vissers MCM, Das AB. Potential mechanisms of action for vitamin C in cancer: reviewing the evidence. Front Physiol. 2018; 9(809). doi:https://doi.org/10.3389/fphys.2018.00809